Chinese biopharmaceutical companies are committed to reshaping the industrial landscape. Combining advanced mRNA technology platforms with AI algorithms can greatly increase speed and efficiency.
mRNA can express any protein and can be explored to treat almost all protein-based diseases. Traditional drug development usually requires a multi-year development process, is costly, and has a high failure rate. Using the AI drug platform to develop new drugs has greatly improved efficiency and significantly reduced time and costs. The combination of mRNA technology and AI is expected to reshape theindustrial landscape.